InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: None

Thursday, 12/06/2018 6:05:24 AM

Thursday, December 06, 2018 6:05:24 AM

Post# of 38634
MALLINCKRODT TO SPIN OFF SPECIALTY GENERICS OPS TO HOLDERS

Transaction expected to create two differentiated pharmaceutical companies with scale - One focused on innovative specialty pharmaceutical brands; One with a portfolio of niche specialty generic products, active pharmaceutical ingredients (APIs), and non-promoted brands including the AMITIZA® product ---- Transaction expected to be completed in the second half of 2019 ---- Spun-off company will assume the Mallinckrodt name; Specialty Pharmaceutical Brands company will be renamed --
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y